Teresa Marafioti

Summary

Publications

  1. pmc The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation
    Teresa Marafioti
    Leukaemia Research Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, OX3 9DU, UK
    Haematologica 95:432-9. 2010
  2. doi request reprint Novel markers of normal and neoplastic human plasmacytoid dendritic cells
    Teresa Marafioti
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Blood 111:3778-92. 2008
  3. ncbi request reprint The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas
    Jennifer C Paterson
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK
    Haematologica 91:772-80. 2006
  4. doi request reprint Labeling of multiple cell markers and mRNA using automated apparatus
    Jennifer C Paterson
    Leukaemia Research Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK
    Appl Immunohistochem Mol Morphol 16:371-81. 2008
  5. ncbi request reprint Transmembrane adaptor molecules: a new category of lymphoid-cell markers
    Sara Tedoldi
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom
    Blood 107:213-21. 2006
  6. ncbi request reprint The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas
    Teresa Marafioti
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Br J Haematol 128:333-42. 2005
  7. pmc Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?
    Goran Mattsson
    1Leukaemia Research Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK
    Haematologica 95:670-3. 2010
  8. ncbi request reprint Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues
    Sermin Ozkal
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK
    Pathol Res Pract 205:781-8. 2009
  9. ncbi request reprint Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells
    Noraidah Masir
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Br J Haematol 127:335-43. 2004
  10. pmc Detection of genetic alterations by immunoFISH analysis of whole cells extracted from routine biopsy material
    Goran Mattsson
    Haematology Department, Level 4, John Radcliffe Hospital, Oxford OX3 9DU, UK
    J Mol Diagn 9:479-89. 2007

Collaborators

Detail Information

Publications19

  1. pmc The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation
    Teresa Marafioti
    Leukaemia Research Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, OX3 9DU, UK
    Haematologica 95:432-9. 2010
    ..Recently, CXCL13, PD-1 and SAP were described as useful markers for T(FH) cells and angioimmunoblastic T-cell lymphoma but also reported in some peripheral T-cell lymphomas, not otherwise specified...
  2. doi request reprint Novel markers of normal and neoplastic human plasmacytoid dendritic cells
    Teresa Marafioti
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Blood 111:3778-92. 2008
    ....
  3. ncbi request reprint The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas
    Jennifer C Paterson
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK
    Haematologica 91:772-80. 2006
    ..It was hypothesized that their expression patterns might yield information on apoptosis as it occurs in normal and reactive lymphoid cells, and also be of value for the detection of lymphoma subtypes...
  4. doi request reprint Labeling of multiple cell markers and mRNA using automated apparatus
    Jennifer C Paterson
    Leukaemia Research Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK
    Appl Immunohistochem Mol Morphol 16:371-81. 2008
    ..Finally, automated labeling could also be performed on peripheral blood and bone marrow smears, opening the possibility of using this procedure in the analysis of hematologic/cytology samples...
  5. ncbi request reprint Transmembrane adaptor molecules: a new category of lymphoid-cell markers
    Sara Tedoldi
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom
    Blood 107:213-21. 2006
    ..These molecules represent a potentially important addition to the panel of immunophenotypic markers detectable in routine biopsies that can be used in hematopathologic studies...
  6. ncbi request reprint The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas
    Teresa Marafioti
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Br J Haematol 128:333-42. 2005
    ..It would be of interest to correlate this feature with patterns of gene expression and also with prognosis, since it may identify a subset of human lymphoma that is distinct in its molecular and clinical features...
  7. pmc Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?
    Goran Mattsson
    1Leukaemia Research Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK
    Haematologica 95:670-3. 2010
    ..Due to the high false positive and negative rates for cNPM in cell smears, this method should not be used as a surrogate for NPM1 mutations in AML...
  8. ncbi request reprint Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues
    Sermin Ozkal
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK
    Pathol Res Pract 205:781-8. 2009
    ....
  9. ncbi request reprint Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells
    Noraidah Masir
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Br J Haematol 127:335-43. 2004
    ..FCRL may therefore represent a novel marker for normal B cells (e.g. splenic marginal zone cells) and may also be useful as a potential marker of B-cell neoplasms...
  10. pmc Detection of genetic alterations by immunoFISH analysis of whole cells extracted from routine biopsy material
    Goran Mattsson
    Haematology Department, Level 4, John Radcliffe Hospital, Oxford OX3 9DU, UK
    J Mol Diagn 9:479-89. 2007
    ..This procedure represents a novel methodology, which in some settings offers clear advantages over analysis of tissue sections...
  11. ncbi request reprint Cancer-associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling
    Charles H Lawrie
    Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, UK
    Int J Cancer 118:3161-6. 2006
    ..271). We suggest that this technique could provide a powerful tool for identifying novel carbohydrates in other cancers...
  12. pmc Follicular lymphoma with trisomy 18 exhibiting loss of BCL-2 expression on transformation to a large cell lymphoma
    Noraidah Masir
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford, UK
    J Clin Pathol 60:1061-4. 2007
  13. ncbi request reprint Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes
    Andrea Pellagatti
    LRF Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, UK
    Br J Haematol 146:86-90. 2009
    ..Downregulation of LEF1 mRNA was reflected at the protein level. Immunostaining for CD34/LEF1 may represent a marker of advanced MDS. LEF1 may play a role in the defective maturation of myeloid progenitors in MDS...
  14. ncbi request reprint MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma
    Charles H Lawrie
    Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
    Int J Cancer 121:1156-61. 2007
    ..001), we suggest that microRNAs could be clinically useful molecular markers for DLBCL as well as other cancers...
  15. ncbi request reprint The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma
    Philip Brown
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Level 5, Room 5501, Oxford, OX3 9DU, UK
    J Mol Histol 36:249-56. 2005
    ..The heterogeneity of FOXP1 expression in germinal centre-derived lymphomas, may have more to do with the transforming events underlying these distinct types of lymphoma than with their common origin...
  16. ncbi request reprint Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease
    Teresa Marafioti
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom
    Haematologica 89:957-64. 2004
    ..In this paper, we have evaluated the usefulness of the pan-leukocyte marker LSP1 and the transcription factor PU.1 for resolving such diagnostic problems...
  17. pmc Immune phenotype predicts risk for posttransplantation squamous cell carcinoma
    Robert P Carroll
    Transplantation Research Immunology Group, Nuffield Department of Surgery, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom
    J Am Soc Nephrol 21:713-22. 2010
    ..In summary, monitoring components of the immune system can predict development of cutaneous SCC among KTRs...
  18. ncbi request reprint Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples
    Michela Pozzobon
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Br J Haematol 124:519-33. 2004
    ..The observation that a range of leucocyte signalling molecules can be detected in routine biopsies offers new possibilities for studying normal and neoplastic human white cells in diagnostic tissue samples...
  19. pmc The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas
    Scott J Rodig
    Department of Pathology, Brigham and Women s Hospital, Boston, MA, USA
    Haematologica 95:2056-62. 2010
    ..Recent profiling studies unexpectedly revealed abundant transcripts of one member of the VpreB family, VpreB3, in a subset of mature B cells and Burkitt lymphoma...